Adamski, Piotr, Poland

• Vol 25, No 3 (2018) - Review articles — Clinical cardiology
  Treatment of patients with acute coronary syndrome: Recommendations for medical emergency teams: Focus on antiplatelet therapies. Updated experts’ standpoint
  Abstract  PDF
• Vol 27, No 6 (2020) - Original articles — Clinical cardiology
  Impact of mild therapeutic hypothermia on bioavailability of ticagrelor in patients with acute myocardial infarction after out-of-hospital cardiac arrest
  Abstract  PDF
• Vol 28, No 4 (2021) - Invited review articles — Clinical cardiology
  A new approach to ticagrelor-based de-escalation of antiplatelet therapy after acute coronary syndrome. A rationale for a randomized, double-blind, placebo-controlled, investigator-initiated, multicenter clinical study
  Abstract  PDF
• Vol 29, No 2 (2022) - Study protocol — Interventional cardiology
  Influence of METHoxyflurane on ANtiplatelet Effect of ticagrelor in patients with unstable angina pectoris: Rationale and a protocol of a randomized clinical METHANE-SIRIO 4 study
  Details  PDF  HTML
• Vol 29, No 1 (2022) - Study protocol — Clinical cardiology
  Low-dose ticagrelor with or without acetylsalicylic acid in patients with acute coronary syndrome: Rationale and design of the ELECTRA-SIRIO 2 trial
  Details  PDF  HTML
• Vol 30, No 3 (2023) - Original articles — COVID-19
  Comparison of reorganized versus unaltered cardiology departments during the COVID-19 era: A subanalysis of the COV-HF-SIRIO 6 study
  Abstract  PDF  HTML
• Vol 30, No 4 (2023) - Experts' viewpoint — Clinical cardiology
  Andexanet alfa — Recommendations for clinical use. Multidisciplinary experts’ standpoint
  Details  PDF  HTML
• Vol 31, No 1 (2024) - Review articles — Clinical cardiology
  Cangrelor — Expanding therapeutic options in patients with acute coronary syndrome
  Abstract  PDF